Pola Penggunaan Obat dan Karakteristik Pasien Diabetes Melitus di Puskesmas Rawat Inap Sidomulyo Pekanbaru Periode Mei-Juni 2026
DOI:
https://doi.org/10.31004/joecy.v6i3.14694Keywords:
Diabetes Mellitus; Aomplications; Age; Gender; Antidiabetic DrugsAbstract
ABSTRACT
Diabetes Mellitus (DM) is a chronic disease that requires long-term management to prevent complications. This study aimed to compare DM patients with and without complications and to describe the profile of antidiabetic drug use at Sidomulyo Inpatient Public Health Center. This study used a descriptive observational method with a retrospective approach based on medical records of 59 DM patients. The results showed that most patients were aged 40–60 years (68%), female (69%), and had hypertension comorbidity (78%). Metformin 500 mg was the most frequently used antidiabetic drug, prescribed to 31 patients (53%), followed by the combination of metformin 500 mg and glimepiride 2 mg in 21 patients (36%). Glimepiride 2 mg monotherapy was used in 3 patients (5%), while the combination of metformin 500 mg and glimepiride 1 mg and glimepiride 1 mg monotherapy were each used in 2 patients (3%). These findings indicate that metformin, either as monotherapy or in combination therapy, was the most commonly used antidiabetic treatment and may provide an overview for evaluating antidiabetic drug use at the health center.
References
American Diabetes Association Professional Practice Committee (2025). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes care, 48(1 Suppl 1), S27–S49. https://doi.org/10.2337/dc25-S002
DiPiro, J. T., DiPiro, C. V., Wells, B. G., & Schwinghammer, T. L. (2023). Pharmacotherapy: A Pathophysiologic Approach (12th ed.). New York: McGraw-Hill Education.
International Diabetes Federation. (2024). IDF Diabetes Atlas 10th Edition. Brussels: IDF
Soelistijo, S. A., Lindarto, D., Decroli, E., et al. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2021. Jakarta: PB PERKENI.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Rahmayati Rusnedy, Ella Elyana, Alfi Hidayah, Indra Arif Firmansyah, Tria Retno Vinasty, Alya Anisa

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.







